Clinical TrialID 131

The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer

NCT04196075

Squamous Cell Carcinoma of Esophagus

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
131
Evidence Id
131
Core Evidence Id
131
Source Clinical Trial Id
126
Herb2 Clinical Trial Id
HBCT000126
Nct Id
NCT04196075
Title
The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
Status
Completed
Phase
Phase 3
Study Result
No
Study Condition
Squamous Cell Carcinoma of Esophagus
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Intervention
DRUG: Andrographis Paniculata
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Supportive_Care
Gender
All
Age
Adult, Older_Adult
Enrollment
30
Outcome Measure
Symptomatic relief and quality of life after AP, Symptomatic relief of Dysphagia and quality of life after treatment Dysphagia measured by Dysphagia score Quality of Life measured by EORTC-QLQ-C30, 4 months
Sponsor Collaborator
Chinese University of Hong Kong
Funded By
OTHER
Location
Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Outside Of US & Canada, 00000, China
Other Id
CRE-2017.616
Start Date
2018-03-01
Primary Completion Date
2021-02-28
Completion Date
2021-06-30
First Posted
2019-12-12
Results First Posted
Last Update Posted
2021-11-08
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04196075
Title Cn
Title En
The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
Bilingual Status
semi_complete